282 related articles for article (PubMed ID: 18261217)
1. Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.
Mathias SD; Gao SK; Miller KL; Cella D; Snyder C; Turner R; Wu A; Bussel JB; George JN; McMillan R; Wysocki DK; Nichol JL
Health Qual Life Outcomes; 2008 Feb; 6():13. PubMed ID: 18261217
[TBL] [Abstract][Full Text] [Related]
2. Immune thrombocytopenic purpura: epidemiology and implications for patients.
Michel M
Eur J Haematol Suppl; 2009 Mar; (71):3-7. PubMed ID: 19200301
[TBL] [Abstract][Full Text] [Related]
3. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation.
Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
Health Qual Life Outcomes; 2007 Feb; 5():11. PubMed ID: 17316442
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in children with chronic immune thrombocytopenia in China.
Zhang H; Wang L; Quan M; Huang J; Wu P; Lu Q; Fang Y
Health Qual Life Outcomes; 2016 Mar; 14():45. PubMed ID: 26979950
[TBL] [Abstract][Full Text] [Related]
5. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in adult primary immune thrombocytopenia.
Sestøl HG; Trangbæk SM; Bussel JB; Frederiksen H
Expert Rev Hematol; 2018 Dec; 11(12):975-985. PubMed ID: 30444433
[No Abstract] [Full Text] [Related]
7. Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey.
Snyder CF; Mathias SD; Cella D; Isitt JJ; Wu AW; Young J
Curr Med Res Opin; 2008 Oct; 24(10):2767-76. PubMed ID: 18715526
[TBL] [Abstract][Full Text] [Related]
8. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.
George JN; Mathias SD; Go RS; Guo M; Henry DH; Lyons R; Redner RL; Rice L; Schipperus MR
Br J Haematol; 2009 Feb; 144(3):409-15. PubMed ID: 19016720
[TBL] [Abstract][Full Text] [Related]
9. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura.
McMillan R; Bussel JB; George JN; Lalla D; Nichol JL
Am J Hematol; 2008 Feb; 83(2):150-4. PubMed ID: 17722072
[TBL] [Abstract][Full Text] [Related]
10. Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia.
Viana R; D'Alessio D; Grant L; Cooper N; Arnold D; Morgan M; Provan D; Cuker A; Hill QA; Tomiyama Y; Ghanima W
Adv Ther; 2021 Dec; 38(12):5791-5808. PubMed ID: 34704193
[TBL] [Abstract][Full Text] [Related]
11. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents.
Barnard D; Woloski M; Feeny D; McCusker P; Wu J; David M; Bussel J; Lusher J; Wakefield C; Henriques S; Blanchette V;
J Pediatr Hematol Oncol; 2003 Jan; 25(1):56-62. PubMed ID: 12544774
[TBL] [Abstract][Full Text] [Related]
12. Patterns and influences in health-related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort.
Flores A; Klaassen RJ; Buchanan GR; Neunert CE
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28111877
[TBL] [Abstract][Full Text] [Related]
13. Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura.
Neunert CE; Buchanan GR; Blanchette V; Barnard D; Young NL; Curtis C; Klaassen RJ
Pediatr Blood Cancer; 2009 Oct; 53(4):652-4. PubMed ID: 19492316
[TBL] [Abstract][Full Text] [Related]
14. Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura.
Szende A; Brazier J; Schaefer C; Deuson R; Isitt JJ; Vyas P
Curr Med Res Opin; 2010 Aug; 26(8):1893-903. PubMed ID: 20553121
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross-sectional survey in China.
Zhou Z; Yang L; Chen Z; Chen X; Guo Y; Wang X; Dong X; Wang T; Zhang L; Qiu Z; Yang R
Eur J Haematol; 2007 Jun; 78(6):518-23. PubMed ID: 17419740
[TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life.
Cooper N; Kruse A; Kruse C; Watson S; Morgan M; Provan D; Ghanima W; Arnold DM; Tomiyama Y; Santoro C; Michel M; Laborde S; Lovrencic B; Hou M; Bailey T; Taylor-Stokes G; Haenig J; Bussel JB
Am J Hematol; 2021 Feb; 96(2):199-207. PubMed ID: 33107998
[TBL] [Abstract][Full Text] [Related]
17. Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology.
Al-Samkari H; Cronin A; Arnold DM; Rodeghiero F; Grace RF
J Thromb Haemost; 2021 Sep; 19(9):2348-2354. PubMed ID: 33974336
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic immune thrombocytopenic purpura: the patients' perspective.
Matzdorff A; Arnold G
Eur J Haematol; 2007 May; 78(5):381-8. PubMed ID: 17331128
[TBL] [Abstract][Full Text] [Related]
19. How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh).
Chakrabarti P; George B; Shanmukhaiah C; Sharma LM; Udupi S; Ghanima W
J Patient Rep Outcomes; 2022 Mar; 6(1):24. PubMed ID: 35303181
[TBL] [Abstract][Full Text] [Related]
20. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
